Atorvastatin Calcium Tablets 10 mg, a) 90 count and b) 500 count bottles, Rx only, Mfd by: Dr. Reddy's Laboratories, Ltd., Srikakulam, INDIA --- NDC 55111-121-05
Published February 7, 2018 · Recall initiated: January 29, 2018
Summary
FDA records drug Class III recall D-0418-2018, published February 7, 2018 and initiated January 29, 2018. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: a) 34,125; b) 3,540 bottles; Lot: Lot numbers: a) T600125, 3/2018; T600201, T600248 5/2018, b) T600125, 3/2018; T600201, and T600248, 5/2018. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability
What to do
Voluntary: Firm initiated · Letter
Get an email if ATORVASTATIN CALCIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Nationwide
- UPC
- 0355111123903
- Lot
- Lot numbers: a) T600125, 3/2018; T600201, T600248 5/2018, b) T600125, 3/2018; T600201, and T600248, 5/2018
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL LaboratoriesNovember 4, 2026
- FDAAtorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count (NDCOctober 22, 2025
- FDAAtorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottleOctober 22, 2025
- FDAPD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDCFebruary 7, 2018
- FDAAtorvastatin Calcium Tablets 40 mg, 90 count bottles, Rx only, Mfd by: Dr. Reddy's Laboratories, Ltd.,February 7, 2018
Questions about this recall
Was Atorvastatin Calcium Tablets 10 mg, a) 90 count and b) 500 count bottles, Rx only, Mfd by: Dr. Reddy's Laboratories, Ltd., Srikakulam, INDIA --- NDC 55111-121-05 recalled?
Yes. FDA published recall D-0418-2018 on February 7, 2018. Reported hazard: Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ATORVASTATIN CALCIUM. UPC: 0355111123903.